A
Power Law company profile
Akebia Therapeutics
Biotech & Life Sciences · Cambridge, United States · Founded 2007 · IPO 2014 Thoroughbred
Valuation
$237M
Market cap · May/2026
Revenue
$236M
Latest reported FY
EBITDA
$25M
Latest reported FY
Featured in
$10B+ revenueThoroughbred · Power Law outcome
Investors
11 investors on Akebia Therapeutics's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Seed
1 investor entered at this stage
Series A
6 investors entered at this stage
Series B+
4 investors entered at this stage
Global footprint
Where Akebia Therapeutics has talent and traffic
AI talent share
0.4%
of workforce is AI talent
(1 of 271 staff)
(1 of 271 staff)
Core AI00%
Other AI10.37%
Non-AI workforce27099.63%
Workforce by country
7
countries with
team presence
team presence
🇺🇸 United States96.8%
🇨🇦 Canada0.5%
🇯🇵 Japan0.5%
🇨🇳 China0.5%
🇪🇸 Spain0.5%
Web traffic by country
10K
monthly visits
across markets
across markets
🇺🇸 United States48%
🇭🇰 Hong Kong15%
🇮🇳 India13%
🇬🇧 United Kingdom13%
🇨🇦 Canada10%
Market sentiment
What the market is saying about Akebia Therapeutics
An AI-synthesized read of the highest-engagement posts about Akebia Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Akebia Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.